Related Experiment Video
Updated: Aug 5, 2026
07:30
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Increased cerebrospinal fluid cyclo(His-Pro) content in schizophrenia
C Prasad1, C W Hilton, J B Lohr
1Department of Medicine, Louisiana State University Medical Center, New Orleans 70112.
Neuropeptides
|November 1, 1991
Summary
Cyclo(His-Pro) (CHP) levels are elevated in the cerebrospinal fluid of individuals with schizophrenia. This peptide may play a role in the hyperdopaminergic state characteristic of this mental health condition.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Cyclo(His-Pro) (CHP) is a naturally occurring peptide found in human brain and cerebrospinal fluid (CSF).
- Previous animal studies indicate that exogenous CHP administration can enhance dopaminergic neurotransmission.
- Schizophrenia is a complex mental disorder often associated with a hyperdopaminergic state.
Purpose of the Study:
- To investigate the potential role of Cyclo(His-Pro) (CHP) in schizophrenia.
- To measure and compare CSF CHP levels in healthy controls, never-medicated schizophrenic patients, and medicated schizophrenic patients.
Main Methods:
- Cerebrospinal fluid (CSF) samples were collected from three groups: controls, never-medicated individuals with schizophrenia, and medicated individuals with schizophrenia.
- Quantitative analysis was performed to determine the concentration of CHP in each CSF sample.
Main Results:
- CSF levels of CHP were found to be significantly increased by 53% in never-medicated schizophrenic patients compared to controls (p = 0.015).
- Medicated schizophrenic patients also showed a 25% increase in CSF CHP levels compared to controls.
- These findings suggest a correlation between elevated CHP levels and schizophrenia.
Conclusions:
- Elevated cerebrospinal fluid (CSF) levels of Cyclo(His-Pro) (CHP) are observed in both never-medicated and medicated individuals with schizophrenia.
- The peptide CHP is implicated as a potential contributor to the hyperdopaminergic symptoms observed in schizophrenia.
- Further research is warranted to elucidate the precise mechanisms by which CHP influences dopaminergic neurotransmission in schizophrenia.
More Related Videos
08:04Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
Published on: November 19, 2020
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
01:21Cerebrospinal Fluid
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...